Novavax
NVAX
#5597
Rank
NZ$2.24 B
Marketcap
NZ$13.63
Share price
1.45%
Change (1 day)
26.53%
Change (1 year)

Novavax (NVAX) - P/B ratio

P/B ratio as of May 2026 : -10.2

According to Novavax's latest financial reports the company has a price-to-book ratio of 1.2076.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Novavax - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31-9.07326.57%
2024-12-31-2.13167.32%
2023-12-31-0.7953-42.29%
2022-12-31-1.38-95.52%
2021-12-31-30.8-371.78%
2020-12-3111.3-1735.05%
2019-12-31-0.6922-83.57%
2018-12-31-4.21-7.94%
2017-12-31-4.58-92.57%
2016-12-31-61.6-896.25%
2015-12-317.7425.48%
2014-12-316.1717.34%
2013-12-315.2650.85%
2012-12-313.4829.53%
2011-12-312.69-41.12%
2010-12-314.5719.85%
2009-12-313.8132.66%
2008-12-312.87-12.14%
2007-12-313.2721.37%
2006-12-312.70-36.5%
2005-12-314.249.54%
2004-12-313.87-33.15%
2003-12-315.80-27.94%
2002-12-318.04

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Novartis
NVS
6.02-158.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.73-116.93%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
5.88-157.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
4.81-146.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
1.99-119.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
4.82-147.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-0.5210-94.91%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
3.87-137.78%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-19.7 92.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
0.7563-107.39%๐Ÿ‡บ๐Ÿ‡ธ USA